Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B-cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia

Sarah Elitzur*, Nira Arad-Cohen, Shlomit Barzilai-Birenboim, Miriam Ben-Harush, Bella Bielorai, Ronit Elhasid, Tamar Feuerstein, Gil Gilad, Alexander Gural, Mira Kharit, Naomi Litichever, Ronit Nirel, Sigal Weinreb, Ofir Wolach, Amos Toren, Shai Izraeli, Elad Jacoby

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B-cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science